Hierarchical inhibition of mTORC1 by glucose starvation-triggered AXIN lysosomal translocation and by AMPK

Abstract

When glucose is replete, mammalian/mechanistic target of rapamycin complex 1 (mTORC1) is active and anchored to the lysosomal surface via the two GTPases, Ras-related GTPase (RAG) and Ras homolog enriched in brain (Rheb), which are regulated by Ragulator and tuberous sclerosis complex 2 (TSC2), respectively. When glucose is low, aldolase senses low fructose-1,6-bisphosphate level and promotes the translocation of AXIN−liver kinase B1 (LKB1) to the lysosomal surface, which leads to the activation of AMP-activated protein kinase (AMPK) and the inhibition of RAGs, sundering mTORC1 from the lysosome and causing its inactivation. AMPK can also inactivate mTORC1 by phosphorylating Raptor and TSC2. However, the hierarchy of AXIN- and AMPK-mediated inhibition of mTORC1 remains poorly defined. Here, we show that AXIN translocation does not require AMPK expression or activity. In glucose starvation conditions, knockout of AXIN extended the half-life of mTORC1 inhibition from 15 to 60 min, whereas knockout of AMPK only extended it to 30 min. RAGB^GTP (constitutively active RAGB) almost entirely blocked the lysosomal dissociation and inhibition of mTORC1 under glucose starvation, but it did not inhibit AMPK, indicating that under these conditions, it is AXIN lysosomal translocation that inhibits mTORC1, and it does so via inhibition of RAGs. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), a mimetic of AMP, which activates both cytosolic AMPK and lysosomal AMPK, fully inhibited mTORC1 even when it is stably anchored to the lysosome by RAGB^GTP, whereas glucose starvation mildly inhibited such anchored mTORC1. Together, we demonstrate that the lysosomal translocation of AXIN plays a primary role in glucose starvation-triggered inhibition of mTORC1 by inhibiting RAGs, and that AMPK activity inhibits mTORC1 through phosphorylating Raptor and TSC2, especially under severe stress.

Keywords

mTORC1 / glucose sensing / AMPK

References

[1] Gonzalez A, Hall MN, Lin SC et al. AMPK and TOR: the Yin and Yang of cellular nutrient sensing and growth control. Cell Metab 2020; 31: 472- 92.

[2] Itani SI, Saha AK, Kurowski TG et al. Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase. Diabetes 2003; 52: 1635- 40.

[3] Suchankova G, Nelson LE, Gerhart-Hines Z et al. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun 2009; 378: 836- 41.

[4] Fang M, Shen Z, Huang S et al. The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell 2010; 143: 711- 24.

[5] Tabidi I, Saggerson D. Inactivation of the AMP-activated protein kinase by glucose in cardiac myocytes: a role for the pentose phosphate pathway. Biosci Rep 2012; 32: 229- 39.

[6] Zhang CS, Hawley SA, Zong Y et al. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature 2017; 548: 112- 6.

[7] Salt IP, Johnson G, Ashcroft SJH et al. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic b cells, and may regulate insulin release. Biochem J 1998; 335: 533- 9.

[8] Dennis PB, Jaeschke A, Saitoh M et al. Mammalian TOR: a homeostatic ATP sensor. Science 2001; 294: 1102- 5.

[9] Gonzalez PS, O’Prey J, Cardaci S et al. Mannose impairs tumour growth and enhances chemotherapy. Nature 2018; 563: 719- 23.

[10] Wen Z, Jin K, Shen Y et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat Immunol 2019; 20: 313- 25.

[11] He J, Shangguan X, Zhou W et al. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development. Nat Commun 2021; 12: 4371.

[12] Haythorne E, Lloyd M, Walsby-Tickle J et al. Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic beta β -cells. Nat Commun 2022; 13: 6754.

[13] Scherlinger M, Pan W, Hisada R et al. Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity. Sci Adv 2022; 8: eadc9657.

[14] Lu M, Holliday LS, Zhang L et al. Interaction between aldolase and vacuolar H⁺-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump. J Biol Chem 2001; 276: 30407- 13.

[15] Li M, Zhang CS, Zong Y et al. Transient receptor potential V channels are essential for glucose sensing by Aldolase and AMPK. Cell Metab 2019; 30: 508- 24.e12.

[16] Nada S, Hondo A, Kasai A et al. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. EMBO J 2009; 28: 477- 89.

[17] Sancak Y, Bar-Peled L, Zoncu R et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010; 141: 290- 303.

[18] Bar-Peled L, Schweitzer LD, Zoncu R et al. Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 2012; 150: 1196- 208.

[19] Zhang CS, Jiang B, Li M et al. The lysosomal v-ATPase-Ragulator complex Is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab 2014; 20: 526- 40.

[20] Li M, Zhang CS, Feng JW et al. Aldolase is a sensor for both low and high glucose, linking to AMPK and mTORC1. Cell Res 2021; 31: 478- 81.

[21] Zhang YL, Guo H, Zhang CS et al. AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation. Cell Metab 2013; 18: 546- 55.

[22] Chapel A, Kieffer-Jaquinod S, Sagne C et al. An extended proteome map of the lysosomal membrane reveals novel potential transporters. Mol Cell Proteomics 2013; 12: 1572- 88.

[23] Nakashima N, Hayashi N, Noguchi E et al. Putative GTPase Gtr1p genetically interacts with the RanGTPase cycle in Saccharomyces cerevisiae. J Cell Sci 1996; 109: 2311- 8.

[24] Shen K, Sabatini DM. Ragulator and SLC38A9 activate the Rag GTPases through noncanonical GEF mechanisms. Proc Natl Acad Sci USA 2018; 115: 9545- 50.

[25] Shen K, Choe A, Sabatini DM. Intersubunit crosstalk in the Rag GTPase heterodimer enables mTORC1 to respond rapidly to amino acid availability. Mol Cell 2017; 68: 552- 65.e8.

[26] Sancak Y, Peterson TR, Shaul YD et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008; 320: 1496- 501.

[27] Kim E, Goraksha-Hicks P, Li L et al. Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 2008; 10: 935- 45.

[28] Tsun Z-Y, Bar-Peled L, Chantranupong L et al. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol Cell 2013; 52: 495- 505.

[29] Kalender A, Selvaraj A, Kim SY et al. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab 2010; 11: 390- 401.

[30] Inoki K, Li Y, Xu T et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003; 17: 1829- 34.

[31] Efeyan A, Zoncu R, Chang S et al. Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival. Nature 2013; 493: 679- 83.

[32] Yang H, Jiang X, Li B et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature 2017; 552: 368- 73.

[33] Saito K, Araki Y, Kontani K et al. Novel role of the small GTPase Rheb: its implication in endocytic pathway independent of the activation of mammalian target of rapamycin. J Biochem 2005; 137: 423- 30.

[34] Orozco JM, Krawczyk PA, Scaria SM et al. Dihydroxyacetone phosphate signals glucose availability to mTORC1. Nat Metab 2020; 2: 893- 901.

[35] Krause U, Bertrand L, Hue L. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. Eur J Biochem 2002; 269: 3751- 9.

[36] Kimura N, Tokunaga C, Dalal S et al. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 2003; 8: 65- 79.

[37] Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115: 577- 90.

[38] Gwinn DM, Shackelford DB, Egan DF et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30: 214- 26.

[39] Caligaris M, Nicastro R, Hu Z et al. Snf1/AMPK fine-tunes TORC1 signaling in response to glucose starvation. Elife. 2023; 12: e84319.

[40] Egan DF, Shackelford DB, Mihaylova MM et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011; 331: 456- 61.

[41] Kim J, Kundu M, Viollet B et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13: 132- 41.

[42] Yoon I, Nam M, Kim HK et al. Glucose-dependent control of leucine metabolism by leucyl-tRNA synthetase 1. Science 2020; 367: 205- 10.

[43] Carling D, Clarke PR, Zammit VA et al. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur J Biochem 1989; 186: 129- 36.

[44] Qi J, Gong J, Zhao T et al. Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue. EMBO J 2008; 27: 1537- 48.

[45] Yuan M, Yan R, Zhang Y et al. CARS senses cysteine deprivation to activate AMPK for cell survival. EMBO J 2021; 40: e108028.

[46] Zhou Q, Hao B, Cao X et al. Energy sensor AMPK gamma regulates translation via phosphatase PPP6C independent of AMPK alpha. Mol Cell 2022; 82: 4700- 11.e12.

[47] Woods A, Cheung PC, Smith FC et al. Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. J Biol Chem 1996; 271: 10282- 90.

[48] Zong Y, Zhang CS, Li M et al. Hierarchical activation of compartmentalized pools of AMPK depends on severity of nutrient or energy stress. Cell Res 2019; 29: 460- 73.

[49] Gowans GJ, Hawley SA, Ross FA et al. AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. Cell Metab 2013; 18: 556- 66.

[50] Corton JM, Gillespie JG, Hawley SA et al. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 1995; 229: 558- 65.

[51] Cool B, Zinker B, Chiou W et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 2006; 3: 403- 16.

[52] Vezina C, Kudelski A, Sehgal SN. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 1975; 28: 721- 6.

[53] Thoreen CC, Kang SA, Chang JW et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 2009; 284: 8023- 32.

[54] Brown EJ, Beal PA, Keith CT et al. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature 1995; 377: 441- 6.

[55] Nakashima N, Noguchi E, Nishimoto T. Saccharomyces cerevisiae putative G protein, Gtr1p, which forms complexes with itself and a novel protein designated as Gtr2p, negatively regulates the Ran/Gsp1p G protein cycle through Gtr2p. Genetics 1999; 152: 853- 67.

[56] Zhang CS, Li M, Wang Y et al. The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK. Nat Metab 2022; 4: 1369- 401.

[57] Gavva NR, Tamir R, Qu Y et al. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 2005; 313: 474- 84.

[58] Ye L, Kleiner S, Wu J et al. TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis. Cell 2012; 151: 96- 110.

[59] Woo JT, Shinohara C, Sakai K et al. Isolation, characterization and biological activities of concanamycins as inhibitors of lysosomal acidification. J Antibiot (Tokyo) 1992; 45: 1108- 16.

[60] Muroi M, Shiragami N, Nagao K et al. Folimycin (concanamycin A), a specific inhibitor of V-ATPase, blocks intracellular translocation of the glycoprotein of vesicular stomatitis virus before arrival to the Golgi apparatus. Cell Struct Funct 1993; 18: 139- 49.

[61] Chia IV, Costantini F. Mouse axin and axin2/conductin proteins are functionally equivalent in vivo. Mol Cell Biol 2005; 25: 4371- 6.

[62] Li J, Knudsen JR, Henriquez-Olguin C et al. AXIN1 knockout does not alter AMPK/mTORC1 regulation and glucose metabolism in mouse skeletal muscle. J Physiol 2021; 599: 3081- 100.

[63] Demetriades C, Doumpas N, Teleman AA. Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell 2014; 156: 786- 99.

[64] Yan L, Findlay GM, Jones R et al. Hyperactivation of mammalian target of rapamycin (mTOR) signaling by a gain-of-function mutant of the Rheb GTPase. J Biol Chem 2006; 281: 19793- 7.

[65] Buerger C, DeVries B, Stambolic V. Localization of Rheb to the endomembrane is critical for its signaling function. Biochem Biophys Res Commun 2006; 344: 869- 80.

[66] Yadav RB, Burgos P, Parker AW et al. mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging. BMC Cell Biol 2013; 14: 3.

[67] Hanker AB, Mitin N, Wilder RS et al. Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling. Oncogene 2010; 29: 380- 91.

[68] Angarola B, Ferguson SM. Weak membrane interactions allow Rheb to activate mTORC1 signaling without major lysosome enrichment. Mol Biol Cell 2019; 30: 2750- 60.

[69] Thomas JD, Zhang YJ, Wei YH et al. Rab1A is an mTORC1 activator and a colorectal oncogene. Cancer Cell 2014; 26: 754- 69.

[70] Fawal MA, Brandt M, Djouder N. MCRS1 binds and couples Rheb to amino acid-dependent mTORC1 activation. Dev Cell 2015; 33: 67- 81.

[71] Hao F, Kondo K, Itoh T et al. Rheb localized on the Golgi membrane activates lysosome-localized mTORC1 at the Golgilysosome contact site. J Cell Sci 2018; 131: jcs208017.

[72] Zhang J, Kim J, Alexander A et al. A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS. Nat Cell Biol 2013; 15: 1186- 96.

[73] Melser S, Chatelain EH, Lavie J et al. Rheb regulates mitophagy induced by mitochondrial energetic status. Cell Metab 2013; 17: 719- 30.

[74] Lawrence RE, Cho KF, Rappold R et al. A nutrient-induced affinity switch controls mTORC1 activation by its Rag GTPase-Ragulator lysosomal scaffold. Nat Cell Biol 2018; 20: 1052- 63.

[75] Tee AR, Blenis J, Proud CG. Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. FEBS Lett 2005; 579: 4763- 8.

[76] Hawley SA, Pan DA, Mustard KJ et al. Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2005; 2: 9- 19.

[77] Woods A, Dickerson K, Heath R et al. Ca²⁺/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2005; 2: 21- 33.

[78] Hurley RL, Anderson KA, Franzone JM et al. The Ca²⁺/ calmoldulin-dependent protein kinase kinases are AMPactivated protein kinase kinases. J Biol Chem 2005; 280: 29060- 6.

[79] Dagon Y, Hur E, Zheng B et al. p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin’s effect on food intake. Cell Metab 2012; 16: 104- 12.

[80] Ling NXY, Kaczmarek A, Hoque A et al. mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress. Nat Metab 2020; 2: 41- 9.

[81] Morrison KR, Smiles WJ, Ling NXY et al. An AMPKalpha2-specific phospho-switch controls lysosomal targeting for activation. Cell Rep 2022; 38: 110365.

[82] Lee MN, Ha SH, Kim J et al. Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb. Mol Cell Biol 2009; 29: 3991- 4001.

[83] Almacellas E, Pelletier J, Manzano A et al. Phosphofructokinases axis controls glucose-dependent mTORC1 activation driven by E2F1. iScience 2019; 20: 434- 48.

[84] Goberdhan DC, Wilson C, Harris AL. Amino acid sensing by mTORC1: intracellular transporters mark the spot. Cell Metab 2016; 23: 580- 9.

[85] Takahara T, Amemiya Y, Sugiyama R et al. Amino acid-dependent control of mTORC1 signaling: a variety of regulatory modes. J Biomed Sci 2020; 27: 87.

[86] Chen J, Ou Y, Luo R et al. SAR1B senses leucine levels to regulate mTORC1 signalling. Nature 2021; 596: 281- 4.

[87] Carroll B, Maetzel D, Maddocks OD et al. Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. Elife 2016; 5: e11058.

[88] Jewell JL, Kim YC, Russell RC et al. Differential regulation of mTORC1 by leucine and glutamine. Science 2015; 347: 194- 8.

[89] Madiraju AK, Alves T, Zhao X et al. Argininosuccinate synthetase regulates hepatic AMPK linking protein catabolism and ureagenesis to hepatic lipid metabolism. Proc Natl Acad Sci USA 2016; 113: E3423- 30.

[90] Adachi Y, De Sousa-Coelho AL, Harata I et al. l-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism. Mol Metab 2018; 17: 61- 70.

[91] Gannon NP, Vaughan RA. Leucine-induced anabolic-catabolism: two sides of the same coin. Amino Acids 2016; 48: 321- 36.

[92] Dalle Pezze P, Ruf S, Sonntag AG et al. A systems study reveals concurrent activation of AMPK and mTOR by amino acids. Nat Commun 2016; 7: 13254.

[93] Ma T, Tian X, Zhang B et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature 2022; 603: 159- 65.

[94] Goorden SM, Hoogeveen-Westerveld M, Cheng C et al. Rheb is essential for murine development. Mol Cell Biol 2011; 31: 1672- 8.

[95] Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature 2019; 567: 305- 7.

[96] Wasserstein RL, Schirm AL, Lazar NA. Moving to a world beyond “P < 0.05”. Am Stat 2019; 73: 1- 19.

RIGHTS & PERMISSIONS

2023 The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.